Nexxt Spine said last week that it won 510(k) clearance from the FDA for its Nexxt Matrixx stand-alone cervical system.
The anterior cervical interbody fusion system is used for the treatment of degenerative disc disease. The device will be used with the bone screw fixation provided and requires no additional fixation.
Nexxt Spine said it’s “eager to to release” the system into the market but did not indicate when.
“This enhancement of the Nexxt Matrixx portfolio was the next natural progression for Nexxt Spine,” president Andy Elsbury said in prepared remarks. “With patient care always top of mind, we strive to develop end products that surgeons prefer and hardware patients can count on. Our Stand Alone Cervical is no exception and will showcase the propensity of Nexxt Matrixx technology to facilitate the body’s natural power of cellular healing for fortified fusion.”
